Zhongchao Inc Cl A (ZCMD) Stock Price, Quote & News

Company Profile

Zhongchao Inc. provides healthcare information, education, and training services to healthcare professionals under their MDMOOC brand in the People's Republic of China. It operates through two segments, MDMOOC services, and Sales of Patented Drugs. The company offers patient management services in the tumor and rare diseases field, internet healthcare services, and pharmaceutical services, and operates an online information platform. It also provides online and onsite health information services...

Industry: Health Information Services

Sector: Healthcare

Phone: 86 21 3220 5987

Website: www.izcmd.com

Address:

841 Yan’an Middle Road, Room 2504, OOCL Tower Jing’An District, Shanghai, China

Ksa966 Sep. 16 at 4:20 PM

$ZCMD 3 to get break even do like reto

0 · Reply

Ksa966 Sep. 16 at 4:19 PM

$ZCMD when this will do like reto from 0.30 to 20

0 · Reply

martyn78 Sep. 16 at 7:49 AM

Been tapped into @_ProfessorGamma for a minute now. The way they spot some of these plays before they run is nuts! Wise to be paying attention to this account, give him a proper follow 👍 $DARE / $ZCMD solid swings

0 · Reply

Sanjaynaik2011 Sep. 12 at 1:15 AM

$ZCMD WOW from $12000+ per stock to less than $0.80??? This CEO/owner did ruined this company and didn't do any justice with the company!! How disgraced kind of CEO is this???!!

0 · Reply

et1000 Sep. 11 at 11:08 PM

Ticker MLEC is the next nano float runner ! Every small float ticker has been running almost 500% recently Would not be surprised if they send MLEC up next. MLEC starting to make its move now! Only 573k shares outstanding! 💎 $MOBX $AIXI $WETO $ZCMD china

1 · Reply

Xen_TorpedoCapital Sep. 10 at 6:23 AM

My model is BULLISH among LOW FLOAT for THURSDAY: #1 $GNLN across #2 STALL to EXP $VIVK REC+ $LBGJ EXP+ $MI & YYAI STA+ $ZCMD EXP- GURE STA- VIVK FULL UNIVERSE (MACRO BASELINE)] Sample Size : 128 targets Top 10 Tickers Evaluated : DCOY, NEXR, MSS, RNAZ, KUST, SEB, NIKI, PWCM, TRIB, PAVS Mean Actual Forward Excursion : +103.35% (p-val: 0.0000) <-- (Baseline Drift) Mean Synthetic Jump : +68.96% Empirical Hit Rate (> Hurdle) : 59.38% (p-val: 0.0000) Brier Score (Calibration) : 0.4881 (0 is perfect) Info. Coef. (ρ) : -0.2092 (p-val: 0.0178) +--------------------------------------------------------- GOD BLESS AMERICA 🇺🇸

1 · Reply

ylcnkpln Sep. 9 at 8:58 AM

$ZCMD A massive breakout/boom is coming.

0 · Reply

ylcnkpln Sep. 9 at 8:58 AM

$ZCMD Now is the exact right time; I won't regret it by Friday.

0 · Reply

ylcnkpln Sep. 9 at 8:57 AM

$ZCMD I need to fill it up by Friday.

0 · Reply

Ksa966 Sep. 7 at 10:38 PM

$ZCMD $ZCMD I hate this stock. I really hate it. I lower my average from 8 to 3nd I want only for or at least 4 or to get break even 🥲😢🥲😢🥲🤕☹️😩😤🤯😓

0 · Reply

Zhongchao prices 4.55M Class A shares at $1.10 in registered direct offering

Jul 23, 2026, 9:00 AM EDT - 1 month ago

Zhongchao Inc. Announces $5.0 Million Registered Direct Offering

2026-06-26T23:50:36.000Z - 2 months ago

Zhongchao Inc trading halted, news pending

2026-06-25T12:05:28.000Z - 2 months ago

Zhongchao implements 1-for-3 share consolidation

Jun 25, 2026, 8:00 AM EDT - 2 months ago

Zhongchao Inc. Announces 1-for-3 Share Consolidation

2026-06-05T23:51:00.000Z - 3 months ago

Zhongchao Inc trading halted, news pending

2026-06-04T12:07:42.000Z - 3 months ago

Zhongchao implements 1-for-31 share consolidation

Jun 4, 2026, 8:00 AM EDT - 3 months ago

Zhongchao Inc. Announces 1-for-31 Share Consolidation

2026-05-29T14:31:23.000Z - 3 months ago

Zhongchao 9.26M share Spot Secondary priced at $0.54

May 29, 2026, 10:00 AM EDT - 3 months ago

Zhongchao Inc. Announces Pricing of $5 Million Best Efforts Public Offering

2026-05-07T22:02:52.000Z - 4 months ago

Zhongchao files to sell 5.56M units

2026-02-28T00:50:11.000Z - 6 months ago

Zhongchao Inc trading halted, news pending

2026-02-26T13:49:00.000Z - 6 months ago

Zhongchao announces 1-for-8 share consolidation

Feb 26, 2026, 8:30 AM EST - 6 months ago

Zhongchao Inc. Announces 1-for-8 Share Consolidation

2024-05-23T20:07:23.000Z - 2 years ago

Zhongchao files $300M mixed securities shelf

Mar 12, 2024, 8:30 AM EDT - 2 years ago

Zhongchao Inc. Announces Successful Medication Assistance Services for Over 7,000 SLE Patients with Approximately 130,000 Units of Medications

2024-02-29T00:50:09.000Z - 2 years ago

Zhongchao Inc trading halted, news pending

2024-02-27T13:09:49.000Z - 2 years ago

Zhongchao announces 1-for-10 share consolidation

Feb 27, 2024, 8:00 AM EST - 2 years ago

Zhongchao Inc. Announces 1-for-10 Share Consolidation

2023-12-11T13:06:39.000Z - 2 years ago

Zhongchao collaborates with health foundation to support cancer treatment

Dec 11, 2023, 8:00 AM EST - 2 years ago

Zhongchao Inc. Collaborates with a Public Health Foundation to Support Sustainable and Effective Cancer Treatments

Oct 23, 2023, 8:00 AM EDT - 2 years ago

Zhongchao Inc. Launches Breast Cancer Follow-up Visit and Health Management Patient Guide Program on Breast Cancer Awareness Day

Sep 25, 2023, 8:00 AM EDT - 2 years ago

Zhongchao Inc. Introduces PRO-Based Disease Management Model for Lung Cancer Patients

Aug 24, 2023, 8:00 AM EDT - 3 years ago

Zhongchao Inc. Announces Serving over 10,000 Breast Cancer Patients with Its Comprehensive Disease Management

Jul 11, 2023, 8:00 AM EDT - 3 years ago

Zhongchao Inc. Partners with Ximalaya to Launch the First Audio Course Series for Cancer Education

Jun 12, 2023, 8:00 AM EDT - 3 years ago

Zhongchao Inc. Launch Digital Online Education Platform for Common Diseases Clinical Diagnosis and Treatment

May 12, 2023, 8:00 AM EDT - 3 years ago

Zhongchao Inc. Announces Strategic Cooperation with Ximalaya

May 8, 2023, 8:00 AM EDT - 3 years ago

Zhongchao Inc. Announces Naiditawei® Enrolled as a Listed Online Procurement Drug in Ten Provinces(Districts, Cities) in China

2023-04-24T12:05:40.000Z - 3 years ago

Zhongchao partners with public health foundation for cancer patient health

Apr 24, 2023, 8:00 AM EDT - 3 years ago

Zhongchao Inc. Partners with a Public Health Foundation to Safeguard Cancer Patients' Health

Mar 30, 2023, 8:00 AM EDT - 3 years ago

Zhongchao Inc. Announces Launch of Health Education Intelligent Content Production Platform

Mar 13, 2023, 8:00 AM EDT - 3 years ago

Zhongchao Inc. Releases Survey Results for Bone Marrow Cancer Patient Services with More than 80% Patients Indicating Full Satisfaction

2023-02-23T13:10:27.000Z - 3 years ago

Zhongchao renews partnership with Johnson & Johnson China

JNJ

Feb 23, 2023, 8:00 AM EST - 3 years ago

Zhongchao Inc. Renews Partnership with Johnson & Johnson (China)

2023-02-13T14:22:50.000Z - 3 years ago

Zhongchao’s MDMOOC Platform to apply ChatGPT technology

Feb 13, 2023, 9:20 AM EST - 3 years ago

Zhongchao Inc. Announces the Application of ChatGPT for Its MDMOOC Platform to Assist Physicians in Clinic Decision Making and Improve Treatment Efficiency

Feb 8, 2023, 7:30 AM EST - 3 years ago

Zhongchao Inc. Announces the Application of ChatGPT to Elevate Patient Management Service Capabilities and Experience

Jan 31, 2023, 7:30 AM EST - 3 years ago

Zhongchao Inc. Announces Introduction of Indian Anti-influenza Drugs to China

Jan 19, 2023, 7:30 AM EST - 3 years ago

Zhongchao Inc. Launches Medication Management Assistance Mini Program to Facilitate Cancer Treatment

Jan 4, 2023, 7:30 AM EST - 3 years ago

Zhongchao Inc. Announces Drug Distributorship in China of Indian Generic Drugs of Natco Pharma Limited

Dec 5, 2022, 7:30 AM EST - 3 years ago

Zhongchao Inc. Established SID Liver Cancer Comprehensive-Disciplinary Physician Education Platform

Nov 3, 2022, 7:30 AM EDT - 3 years ago

Zhongchao Inc.'s China Operating Entity, Chongqing Xinjiang Pharmaceutical Co., Ltd. Obtained Pharmaceutical Trade and Medical Device Operation Licenses, Ready to Enter Into Pharmaceuticals Circulation Market

Sep 28, 2022, 9:18 AM EDT - 3 years ago

Zhongchao Inc. Establishes Chongqing Xinjiang Pharmaceutical Co., Ltd. to Improve Patient Access to Medications

Sep 15, 2022, 7:30 AM EDT - 4 years ago

Zhongchao Inc. Establishes Zhixun Internet Hospital to Provide Patient with Management Services Focusing on the Oncology and Other Major Diseases

Sep 1, 2022, 7:30 AM EDT - 4 years ago

Zhongchao Inc. Announces its New Strategy Extension Focusing on the Oncology and Other Major Disease Management

Jun 13, 2022, 6:30 AM EDT - 4 years ago

Zhongchao Inc. Announces its MDMOOC Platform Launched Disease Prevention and Distribution Quality Management Course

May 9, 2022, 6:30 AM EDT - 4 years ago

Zhongchao Inc. Reports the Fiscal Year 2021 Financial Results

Oct 29, 2021, 6:30 AM EDT - 4 years ago

Zhongchao Inc. Announces Its Patient Management System Improves Its Liver Cancer Patients' Duration of Therapy by 40%, Promoting Successful Treatment

Sep 17, 2021, 6:30 AM EDT - 5 years ago

Zhongchao Inc. Launches Hematology MDT Training Platform to Improve Diagnosis and Treatment

Sep 10, 2021, 6:30 AM EDT - 5 years ago

Zhongchao Inc. Announces Hematological Tumor Patient Management Business to Further Expand to Out-of-Hospital Market

Aug 12, 2021, 8:30 AM EDT - 5 years ago

Zhongchao Inc. Builds A Patient DOT Management System

Jul 27, 2021, 8:30 AM EDT - 5 years ago

Zhongchao Inc. Builds A Platform for Breast Cancer Tiered Diagnosis and Treatment Improvement To Promote the Equalization of Breast Cancer Diagnosis and Treatment Level

Jul 1, 2021, 8:30 AM EDT - 5 years ago

Zhongchao Inc. Announces the Establishment of a New Subsidiary Ningxia Zhongxin Internet Hospital Co., Ltd. for Patient Management

May 28, 2021, 6:30 AM EDT - 5 years ago

Zhongchao Inc. Launched New Line of Business Focusing on Tumor and Rare Disease Patient Management

Apr 30, 2021, 9:00 AM EDT - 5 years ago

Zhongchao Inc. Reports the Fiscal Year 2020 Financial Results

Mar 17, 2021, 6:30 AM EDT - 5 years ago

Zhongchao Renews Contract with China Association of Health Promotion and Education and GlaxoSmithKline

Jan 13, 2021, 6:30 AM EST - 5 years ago

Zhongchao Inc. Promotes Standardized Liver Cancer Diagnosis and Treatment with Medical Associations and Experts

Dec 10, 2020, 8:53 AM EST - 5 years ago

6 Health Care Stocks Trading With Low Price-Earnings Ratios

YCBD

Nov 12, 2020, 6:30 AM EST - 5 years ago

Zhongchao Inc. and Takeda Pharmaceutical Expand Scope of Cooperation in China

Ksa966 Sep. 16 at 4:20 PM

$ZCMD 3 to get break even do like reto

0 · Reply

Ksa966 Sep. 16 at 4:19 PM

$ZCMD when this will do like reto from 0.30 to 20

0 · Reply

martyn78 Sep. 16 at 7:49 AM

0 · Reply

Sanjaynaik2011 Sep. 12 at 1:15 AM

$ZCMD WOW from $12000+ per stock to less than $0.80??? This CEO/owner did ruined this company and didn't do any justice with the company!! How disgraced kind of CEO is this???!!

0 · Reply

et1000 Sep. 11 at 11:08 PM

1 · Reply

Xen_TorpedoCapital Sep. 10 at 6:23 AM

1 · Reply

ylcnkpln Sep. 9 at 8:58 AM

$ZCMD A massive breakout/boom is coming.

0 · Reply

ylcnkpln Sep. 9 at 8:58 AM

$ZCMD Now is the exact right time; I won't regret it by Friday.

0 · Reply

ylcnkpln Sep. 9 at 8:57 AM